Posted by: admin on: December 8, 2011
A femoral artery closure device may reduce large hematomas and speed closure compared with manual compression of the catheter access wound, a randomized trial indicated. Inhospital hematomas larger than 5 cm occurred in 2.2% of patients treated with the FemoSeal device compared with a hematoma rate of 6.7% in patients treated with manual compression alone
Posted by: admin on: December 8, 2011
Asprin is the drug we invariably use for all cardiac patients to prevent cerebrovascular accidents. Here is something to show that clinical trials are not sufficient enough to prove its undoubted benefits. Team@CMHF